Since PZH inhibits tumor metastasis, we examined the expression of VEGF-C, VEGFR-3, and LYVE-1, and found that PZH downregulated these genes expression, indicating that PZH could inhibit tumor lymphangiogenesis in colorectal cancer. The gene discussed is LYVE1; the disease is neoplasm.